Epigenomics AG Demonstrates Feasibility of Convenient Blood Test for Lung Cancer Detection in Clinical Study
June 27th, 2007
Epigenomics AG takes a further step towards launching a convenient blood-based lung cancer screening test that could considerably improve the early detection of lung cancer, the most common cause of cancer-related death. The molecular diagnostics company today announced positive data resulting from a clinical study as part of its lung cancer screening test development program.